| http://dbpedia.org/ontology/abstract
|
モザバプタン（Mozavaptan）バソプレシン受容体阻害薬である。商品名フィズリン。1989年に大塚製薬が創薬した。2001年に希少疾病用医薬品に指定され、2006年7月に承認された。
, Mozavaptan (INN) is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors.
|
| http://dbpedia.org/ontology/casNumber
|
137975-06-5
|
| http://dbpedia.org/ontology/chEMBL
|
420762
|
| http://dbpedia.org/ontology/fdaUniiCode
|
17OJ42922Y
|
| http://dbpedia.org/ontology/pubchem
|
119369
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mozavaptan_structure.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://web.archive.org/web/20120213003638/http:/www.prous.com/molecules/default.asp%3FID=153%7Carchive-date +
, http://www.prous.com/molecules/default.asp%3FID=153 +
|
| http://dbpedia.org/ontology/wikiPageID
|
18594493
|
| http://dbpedia.org/ontology/wikiPageLength
|
2910
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120071879
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Hyponatremia +
, http://dbpedia.org/resource/Category:Benzazepines +
, http://dbpedia.org/resource/Syndrome_of_inappropriate_antidiuretic_hormone +
, http://dbpedia.org/resource/Sodium +
, http://dbpedia.org/resource/Category:Diuretics +
, http://dbpedia.org/resource/Otsuka_Pharmaceutical_Co. +
, http://dbpedia.org/resource/Category:2-Tolyl_compounds +
, http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
, http://dbpedia.org/resource/Vasopressin_receptor_antagonist +
, http://dbpedia.org/resource/International_Nonproprietary_Name +
, http://dbpedia.org/resource/Category:Benzanilides +
|
| http://dbpedia.org/property/atcPrefix
|
none
|
| http://dbpedia.org/property/c
|
27
|
| http://dbpedia.org/property/casNumber
|
137975
|
| http://dbpedia.org/property/chembl
|
420762
|
| http://dbpedia.org/property/chemspiderid
|
106618
|
| http://dbpedia.org/property/h
|
29
|
| http://dbpedia.org/property/iupacName
|
N-[4-phenyl]-2-methylbenzamide
|
| http://dbpedia.org/property/iupharLigand
|
2197
|
| http://dbpedia.org/property/legalStatus
|
Rx-only
|
| http://dbpedia.org/property/n
|
3
|
| http://dbpedia.org/property/o
|
2
|
| http://dbpedia.org/property/pubchem
|
119369
|
| http://dbpedia.org/property/routesOfAdministration
|
Oral
|
| http://dbpedia.org/property/smiles
|
Cc1ccccc1CNc2cccCN3c4ccccc4CNC
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
WRNXUQJJCIZICJ-UHFFFAOYSA-N
|
| http://dbpedia.org/property/unii
|
17
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
462255885
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Diuretics +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Antihypertensive-stub +
, http://dbpedia.org/resource/Template:Cite_journal +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Oxytocin_and_vasopressin_receptor_modulators +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Ebicite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Benzazepines +
, http://dbpedia.org/resource/Category:Vasopressin_receptor_antagonists +
, http://dbpedia.org/resource/Category:Benzanilides +
, http://dbpedia.org/resource/Category:Diuretics +
, http://dbpedia.org/resource/Category:2-Tolyl_compounds +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antagonist +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Mozavaptan?oldid=1120071879&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mozavaptan_structure.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Mozavaptan +
|
| owl:sameAs |
http://dbpedia.org/resource/Mozavaptan +
, http://www.wikidata.org/entity/Q12746116 +
, https://global.dbpedia.org/id/JKdT +
, http://sh.dbpedia.org/resource/Mozavaptan +
, http://yago-knowledge.org/resource/Mozavaptan +
, http://ja.dbpedia.org/resource/%E3%83%A2%E3%82%B6%E3%83%90%E3%83%97%E3%82%BF%E3%83%B3 +
, http://vi.dbpedia.org/resource/Mozavaptan +
, http://fa.dbpedia.org/resource/%D9%85%D9%88%D8%B2%D8%A7%D9%88%D8%A7%D9%BE%D8%AA%D8%A7%D9%86 +
, http://sr.dbpedia.org/resource/Mozavaptan +
, http://rdf.freebase.com/ns/m.04g1msq +
|
| rdf:type |
http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/WikicatDiuretics +
, http://dbpedia.org/class/yago/DiureticDrug103214670 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/WikicatHormonalAgents +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://dbpedia.org/class/yago/Agent109190918 +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/Drug103247620 +
|
| rdfs:comment |
モザバプタン（Mozavaptan）バソプレシン受容体阻害薬である。商品名フィズリン。1989年に大塚製薬が創薬した。2001年に希少疾病用医薬品に指定され、2006年7月に承認された。
, Mozavaptan (INN) is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors.
|
| rdfs:label |
モザバプタン
, Mozavaptan
|
